Literature DB >> 28984384

The role of the long non-coding RNA TDRG1 in epithelial ovarian carcinoma tumorigenesis and progression through miR-93/RhoC pathway.

Shuo Chen1, Li-Li Wang1, Kai-Xuan Sun1, Yin-Ling Xiu1, Zhi-Hong Zong2, Xi Chen1, Yang Zhao1.   

Abstract

As one of the most frequently diagnosed cancers in women, the development and progression of epithelial ovarian carcinoma (EOC) remains an open area of research. The role of long non-coding RNAs (lncRNAs) in EOC is an emerging field of study. We found that LncRNA TDRG1 (human testis development-related gene 1) was highly expressed in EOC tissues than in normal ovarian tissues, and expression differed significantly with differentiation. LncRNA TDRG1 downregulation suppressed EOC cell proliferation, migration, and invasion, while its overexpression had the opposite effect. Bioinformatic predictions and dual-luciferase reporter assays showed that LncRNA TDRG1 has possible miRNA-93 (miR-93) binding sites. LncRNA TDRG1 downregulation upregulated miR-93 expression, while its overexpression reduced miR-93 expression. In addition, TDRG1 downregulation reduced the expression of Ras homolog gene family member C (RhoC), P70 ribosomal S6 kinase (P70S6 K), Bcl-xL, and matrix metalloproteinase 2 (MMP2) protein, which are regulated by miR-93, while its upregulation induced RhoC, P70S6 K, Bcl-xL, and MMP2 protein expression. In vivo, LncRNA TDRG1 overexpression induced tumor development and RhoC expression. Taken together, our results demonstrated for the first time that LncRNA TDRG1 may be a new and important diagnostic and therapeutic target in EOC.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  epithelial ovarian carcinoma; lncRNA TDRG1; progression miR-93; tumorigenesis

Mesh:

Substances:

Year:  2017        PMID: 28984384     DOI: 10.1002/mc.22749

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  8 in total

1.  Long non-coding RNA TDRG1 facilitates cell proliferation, migration and invasion in breast cancer via targeting miR-214-5p/CLIC4 axis.

Authors:  Yanrong Lv; Ke Dong; Haidong Gao
Journal:  Cancer Biol Ther       Date:  2021-04-06       Impact factor: 4.742

2.  LncRNA TDRG1 Promotes Proliferation, Invasion and Epithelial-Mesenchymal Transformation of Osteosarcoma Through PI3K/AKT Signal Pathway.

Authors:  Yan Huang; Yong-Qiang Xu; Si-Yin Feng; Xiang Zhang; Jiang-Dong Ni
Journal:  Cancer Manag Res       Date:  2020-06-15       Impact factor: 3.989

3.  The lncRNA TDRG1 promotes cell proliferation, migration and invasion by targeting miR-326 to regulate MAPK1 expression in cervical cancer.

Authors:  Hui Jiang; Min Liang; Yanqiong Jiang; Ting Zhang; Kexin Mo; Suwen Su; Aiping Wang; Yongyi Zhu; Guanqun Huang; Rujian Zhou
Journal:  Cancer Cell Int       Date:  2019-05-31       Impact factor: 5.722

4.  Knockdown of lncRNA TDRG1 Inhibits Tumorigenesis in Endometrial Carcinoma Through the PI3K/AKT/mTOR Pathway.

Authors:  Ruimei Sun; Xiujiang Sun; Hua Liu; Peirui Li
Journal:  Onco Targets Ther       Date:  2019-12-11       Impact factor: 4.147

5.  Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR-454 and ZEB1.

Authors:  YinYing Wu; Bo Zhu; Yanli Yan; Shuheng Bai; Haojing Kang; Jiangzhou Zhang; Wen Ma; Ying Gao; Beina Hui; Rong Li; Xiaozhi Zhang; Juan Ren
Journal:  Mol Oncol       Date:  2021-03-19       Impact factor: 6.603

Review 6.  LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.

Authors:  Eleonora A Braga; Marina V Fridman; Alexey A Moscovtsev; Elena A Filippova; Alexey A Dmitriev; Nikolay E Kushlinskii
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

7.  The rs8506 TT Genotype in lincRNA-NR_024015 Contributes to the Risk of Sepsis in a Southern Chinese Child Population.

Authors:  Jinqing Li; Huazhong Zhou; Bing Wei; Di Che; Yufen Xu; Lei Pi; Lanyan Fu; Jie Hong; Xiaoqiong Gu
Journal:  Front Public Health       Date:  2022-07-13

8.  Long non-coding RNA TDRG1 promotes hypoxia-induced glycolysis by targeting the miR-214-5p/SEMA4C axis in cervical cancer cells.

Authors:  Xiaomei Li; Chunxiao Zhang; Yongju Tian
Journal:  J Mol Histol       Date:  2021-01-04       Impact factor: 2.611

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.